SCHEMBL19081492

SCHEMBL19081492

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5c6oc7ccccc7c6cc6c5oc5cc7ccccc7cc56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.37
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
ESR1 P03372 4/20 0.35
ESR2 Q92731 4/20 0.35
AHR P35869 2/20 0.35
ALOX5 P09917 1/20 0.33
HCRTR1 O43613 1/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945213 0.94 PGR (0.41) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL17944060 0.90 ESR1 (0.39) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL26492260 0.90 ESR1 (0.41) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL20127669 0.90 CYP1A1 (0.40) PLA2G2APLA2G4AESR1ESR2AHR
SCHEMBL19081599 0.89 ALOX5 (0.36) PLA2G2APLA2G4AESR1ESR2AHR
SCHEMBL10122331 0.88 HSD17B1 (0.40) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL10122350 0.88 ESR1 (0.40) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL19081485 0.88 PGR (0.34) PGRPLA2G2APLA2G4AESR1ESR2
SCHEMBL10122341 0.88 AHR (0.41) PLA2G2APLA2G4AESR1ESR2AHR
SCHEMBL17931927 0.86 ESR1 (0.38) PGRPLA2G2APLA2G4AESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PGR 1721/4885PLA2G2A 4330/4885PLA2G4A 4338/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PGR 1721/4885PLA2G2A 4330/4885PLA2G4A 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.